Human herpesvirus Epstein-Barr (EBV) and Its porcine homologs unveil the conser ved mechanism of receptor endocytosis: new insights into viral immune evasion and antiviral therapy potential?Kubale, Valentina (Avtor) Epstein-Barr virusporcine homologsreceptorsantiviral therapyswineOver the past two years, the University of Ljubljana and the Republic of Slovenia’s public agency, the Slovenian Research and Innovation Service (ARIS), have acknowledged and celebrated several exceptional accomplishments in viral receptor research. These achievements are considered among the finest by both the University of Ljubljana and ARIS. The significance of these achievements lies in the research findings, which indicate that the EBV-BILF1 receptor encoded by the Epstein-Barr virus (EBV) could become a promising new drug target for EBV. Additionally, the research suggests pigs represent a great model for further investigations (1–4).20242025-01-23 14:39:36Članek v reviji166745UDK: 616.523:636.4ISSN pri članku: 1580-4003DOI: 10.26873/SVR-2053-2024COBISS_ID: 221153539sl